POSSIBLE CORRELATION OF B3-A2-TYPE BCR-ABL MESSENGER-RNA DEFINED BY SEMIQUANTITATIVE RT-PCR TO PLATELET AND MEGAKARYOCYTE COUNTS IN PHILADELPHIA-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA

被引：11

作者：

INOKUCHI, K

FUTAKI, M

DAN, K

NOMURA, T

机构：

[1] Department of Internal Medicine, Nippon Medical School, Tokyo

来源：

INTERNAL MEDICINE | 1994年 / 33卷 / 04期

关键词：

THROMBOPOIESIS; CML; BCR-ABL GENE;

D O I：

10.2169/internalmedicine.33.189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Thirty-five patients with Philadelphia chromosome (Ph1)-positive chronic myelogenous leukemia (CML) were classified on the basis of the fusion pattern of bcr-abl mRNA determined by the reverse-transcriptase-polymerase chain reaction (RT-PCR) method. Semiquantitative assay of the bcr exon 2/abl exon 2 fused mRNA (b2-a2) and bcr exon 3/abl exon 2 fused mRNA (b3-a2) resulted in 21 patients showing b3-a2 type mRNA, seven showing b2-a2 type and seven showing coexpression. Quantification of the autoradiographic signals of amplified products was estimated using an MCID image analysis system. The relative intensity was defined as the ratio of bcr-abl signal to that of beta-actin. The relationship between the semiquantified bcr-abl mRNA and the platelet/megakaryocyte counts was analyzed. A possible correlation was found between the semiquantified b3-a2 type mRNA and the platelet (p < .05, N = 28) and megakaryocyte (p < .05, N = 13) counts of these patients. This finding suggests the possibility that b3-a2 mRNA may affect the thrombopoietic activity in Ph1-positive CML in a dose-response manner.

引用

页码：189 / 192

页数：4

共 13 条

[1]

Masson J.E., DeVita V.T., Canellos G.P., Thrombocytosis in chronic granulocytic leukemia: Incidence and clinical significance, Blood, 44, (1974)

[2]

Inokuchi K., Futaki M., Yamada T., Et al., The relationship between the site of breakpoints within the bcr gene and thrombopoiesis of Philadelphiapositive chronic myelocytic leukemia, Leukem Res, 15, (1991)

[3]

Inokuchi K., Inoue T., Tojo A., Et al., A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphiapositive chronic myelogenous leukemia, Blood, 78, (1991)

[4]

Futaki M., Inokuchi K., Matsuoka H., Miyake K., Dan K., Nomura T., Relationship of the type of bcr-abl hybrid mRNA to clinical course and transforming activity in Philadelphia-positive chronic myelogenous leukemia, Leukem Res, 16, (1992)

[5]

Inokuchi K., Nomura T., The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia, Leukem Lymphom, 10, (1993)

[6]

Inokuchi K., Futaki M., Miyake M., Et al., Molecular breakpoints and platelet counts in chronic myeloid leukemia

[7]

response, Blood, 80, (1992)

[8]

Cervantes F., Urbano-Ispizua A., Villamor N., Et al., Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis: report of two cases with molecular studies, Leukemia, 7, (1993)

[9]

Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18, (1979)

[10]

Roth M.S., Antin J.H., Bingham E.L., Ginsburg D., Detection of Philadelphiapositive cells by polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia, Blood, 74, (1989)

← 1 2 →